Requip News
GlaxoSmithKline receives decision from US FDA on Requip XL - Prdomain Business Register (press release)
This decision does not affect the immediate-release formulation of Requip® (ropinirole hydrochloride) Tablets, which is dosed three times a day and remains ...
GSK Announces Regulatory Approvals For Requip-Modutab, The First ... - Medical News Today (press release)
GlaxoSmithKline announced the approval of Requip Modutab* (ropinirole prolonged release tablets) in eight European countries**. ...
SkyePharma buoyed by drug's FDA progress - ShareCast
The FDA has issued an approvable letter for GlaxoSmithKline’s Requip XL Extended Release tablets, which use SkyePharma’s patented Geomatrix technology. ...
Southern Cross shares fail to sparkle - nebusiness.co.uk
glaxosmithkline has received an approval letter from the US Food and Drug Administration for Requip, its treatment for Parkinson’s disease. ...
GSK enters into $1.4 billion cancer pact with oncomed - Pharma Times (subscription)
GSK also noted that it has decided not to pursue an application to market Requip CR, a controlled-release formulation of the drug, for the treatment of ...
Big pharma? Generics are the way to go - BloggingStocks
... has received tentative approval from US health regulators to market its generic version of GlaxoSmithKline Plc's (NYSE: GSK) Requip (Ropinirole HCl) ...
Teva Announces Tentative Approval of Generic Requip® Tablets - Business Wire (press release)
Upon final approval, Teva’s product will be the AB-rated generic equivalent of Requip® Tablets, and will be indicated for the treatment of the signs and ...
Teva Pharmaceutical Industries Ltd declares FDA's tentative ... - Trading Markets (press release)
Upon final approval, Teva's product will reportedly be the AB-rated generic equivalent of Requip Tablets. It will be indicated for the treatment of the ...
Market Report -- In Play (TEVA) - MSN Money
Teva Pharm announces tentative approval of generic Requip tablets Co announces FDA has granted tentative approval for the Abbreviated New Drug Application ...
Teva Pharma Industries Wins Tentative Approval To Market Its ... - Trading Markets (press release)
Upon receipt of the final approval, Teva's product would be the AB-rated generic equivalent of Requip Tablets, and would be indicated for the treatment of ...
Requip RSS Feed